Cart
sales@molnova.com
ML298
CAS No. 1426916-02-0
ML298( CID53393915 )
Catalog No. M23583 CAS No. 1426916-02-0
ML298 is a potent, specific inhibitor of Phospholipase D2 (PLD2, IC50 of 355 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 208 | In Stock |
|
| 50MG | 303 | In Stock |
|
| 100MG | 452 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML298
-
NoteResearch use only, not for human use.
-
Brief DescriptionML298 is a potent, specific inhibitor of Phospholipase D2 (PLD2, IC50 of 355 nM).
-
DescriptionML298 is a potent, specific inhibitor of Phospholipase D2 (PLD2, IC50 of 355 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsCID53393915
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPLD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1426916-02-0
-
Formula Weight432.4
-
Molecular FormulaC22H23F3N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1CN(CCC12C(=O)NCN2C3=CC(=CC=C3)F)CCNC(=O)C4=CC(=C(C=C4)F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brown K A . Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-Triazaspiro[4.5]decane Core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cells.[J]. Journal of Medicinal Chemistry, 2013, 56(6):2695.
molnova catalog
related products
-
Darapladib
A potent Lp-PLA2 inhibitor with IC50 of 0.25 nM.
-
Giripladib
Giripladib (PLA695)(PLX-695) is a cPLA2-specific inhibitor that inhibits the radiation-induced increase of phosphorylated ERK and phosphorylated Akt in endothelial cells.
-
PGMI-004A
PGMI-004A is an effective inhibitor of phosphoglycerate mutase 1 (IC50: 13.1 μM).
